Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds

Pharmacology and Therapeutics

Volumn 152, Issue , 2015, Pages 28-41

  Sundahl, Nora ^a   Bridelance, Jolien ^a   Libert, Claude ^a   De Bosscher, Karolien ^a   Beck, Ilse M ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Compound A; Glucocorticoid receptor; Glucocorticoid resistance; Glucocorticoids; Selective glucocorticoid receptor modulator; Side effects

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; SELECTIVE GLUCOCORTICOID RECEPTOR AGONIST; SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG BINDING; DRUG MECHANISM; GENETIC TRANSCRIPTION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; TRANSACTIVATION; AGONISTS; ANIMAL; BINDING SITE; DRUG EFFECTS; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BINDING SITES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84933673873     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2015.05.001     Document Type: Review

References (154)

1. S.M. Abraham, T. Lawrence, A. Kleiman, P. Warden, M. Medghalchi, and J. Tuckermann Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 J Exp Med 203 2006 1883 1889
2. C. Avenant, K. Ronacher, E. Stubsrud, A. Louw, and J.P. Hapgood Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity Mol Cell Endocrinol 327 2010 72 88
3. E. Ayroldi, A. Macchiarulo, and C. Riccardi Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective FASEB J 28 2014 5055 5070
4. E. Ayroldi, and C. Riccardi Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action FASEB J 23 2009 3649 3658
5. M. Baiula, A. Bedini, J. Baldi, M.E. Cavet, P. Govoni, and S. Spampinato Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy Drug Des Devel Ther 8 2014 745 757
6. P.J. Barnes Glucocorticosteroids: current and future directions Br J Pharmacol 163 2011 29 43
7. U. Baschant, N.E. Lane, and J. Tuckermann The multiple facets of glucocorticoid action in rheumatoid arthritis Nat Rev Rheumatol 8 2012 645 655
8. I.M. Beck, Z.J. Drebert, R. Hoya-Arias, A.A. Bahar, M. Devos, and D. Clarisse Compound A, a selective glucocorticoid receptor modulator, enhances heat shock protein Hsp70 gene promoter activation PLoS One 8 2013 (e69115)
9. I.M. Beck, W. Vanden Berghe, L. Vermeulen, K.R. Yamamoto, G. Haegeman, and K. De Bosscher Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases Endocr Rev 30 2009 830 882
10. M.G. Belvisi Regulation of inflammatory cell function by corticosteroids Proc Am Thorac Soc 1 2004 207 214
11. M.G. Belvisi, T.J. Brown, S. Wicks, and M.L. Foster New Glucocorticosteroids with an improved therapeutic ratio? Pulm Pharmacol Ther 14 2001 221 227
12. K. Biggadike, R.K. Bledsoe, D.M. Coe, T.W. Cooper, D. House, and M.A. Iannone Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor Proc Natl Acad Sci U S A 106 2009 18114 18119
13. R.K. Bledsoe, V.G. Montana, T.B. Stanley, C.J. Delves, C.J. Apolito, and D.D. McKee Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition Cell 110 2002 93 105
14. R.D. Blind, and M.J. Garabedian Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes J Steroid Biochem Mol Biol 109 2008 150 157
15. C. Boyd, and A. Naray-Fejes-Toth Steroid-mediated regulation of the epithelial sodium channel subunits in mammary epithelial cells Endocrinology 148 2007 3958 3967
16. P.E. Brandish, K. Anderson, G.A. Baltus, C. Bai, C.J. Bungard, and P. Bunting The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator Eur J Pharmacol 724 2014 102 111
17. C.J. Bungard, G.D. Hartman, J.J. Manikowski, J.J. Perkins, C. Bai, and P.E. Brandish Discovery of selective glucocorticoid receptor modulator MK-5932 Bioorg Med Chem 19 2011 7374 7386
18. E. Carballo-Jane, S. Pandit, J.C. Santoro, C. Freund, S. Luell, and G. Harris Skeletal muscle: a dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation J Steroid Biochem Mol Biol 88 2004 191 201
19. M.W. Carson, J.G. Luz, C. Suen, C. Montrose, R. Zink, and X. Ruan Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design J Med Chem 57 2014 849 860
20. M.E. Cavet, S. Volhejn, K.L. Harrington, and J.Z. Zhang Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells Mol Vis 19 2013 1515 1525
21. K.E. Chapman, A.E. Coutinho, Z. Zhang, T. Kipari, J.S. Savill, and J.R. Seckl Changing glucocorticoid action: 11beta-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation J Steroid Biochem Mol Biol 137 2013 82 92
22. E. Charmandari, G.P. Chrousos, G.I. Lambrou, A. Pavlaki, H. Koide, and S.S. Ng Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man PLoS One 6 2011 (e25612)
23. E. Charmandari, T. Kino, T. Ichijo, and G.P. Chrousos Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder J Clin Endocrinol Metab 93 2008 1563 1572
24. W. Chen, T. Dang, R.D. Blind, Z. Wang, C.N. Cavasotto, and A.B. Hittelman Glucocorticoid receptor phosphorylation differentially affects target gene expression Mol Endocrinol 22 2008 1754 1766
25. J.E. Chivers, W. Gong, E.M. King, J. Seybold, J.C. Mak, and L.E. Donnelly Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids Mol Pharmacol 70 2006 2084 2095
26. A.R. Clark, and M.G. Belvisi Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor Pharmacol Ther 134 2012 54 67
27. R.D. Clark, N.C. Ray, K. Williams, P. Blaney, S. Ward, and P.H. Crackett 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity Bioorg Med Chem Lett 18 2008 1312 1317
28. M.J. Coghlan, P.B. Jacobson, B. Lane, M. Nakane, C.W. Lin, and S.W. Elmore A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects Mol Endocrinol 17 2003 860 869
29. K. De Bosscher Selective glucocorticoid receptor modulators J Steroid Biochem Mol Biol 120 2010 96 104
30. K. De Bosscher, I.M. Beck, L. Dejager, N. Bougarne, A. Gaigneaux, and S. Chateauvieux Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-kappaB and AP-1 Cell Mol Life Sci 71 2014 143 163
31. K. De Bosscher, I.M. Beck, and G. Haegeman Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system? Brain Behav Immun 24 2010 1035 1042
32. K. De Bosscher, G. Haegeman, and D. Elewaut Targeting inflammation using selective glucocorticoid receptor modulators Curr Opin Pharmacol 10 2010 497 504
33. K. De Bosscher, W. Vanden Berghe, I.M. Beck, W. Van Molle, N. Hennuyer, and J. Hapgood A fully dissociated compound of plant origin for inflammatory gene repression Proc Natl Acad Sci U S A 102 2005 15827 15832
34. K. De Bosscher, W. Vanden Berghe, and G. Haegeman Cross-talk between nuclear receptors and nuclear factor kappaB Oncogene 25 2006 6868 6886
35. L. Dejager, S. Vandevyver, I. Petta, and C. Libert Dominance of the strongest: inflammatory cytokines versus glucocorticoids Cytokine Growth Factor Rev 25 2014 21 33
36. B.J. Deroo, C. Rentsch, S. Sampath, J. Young, D.B. DeFranco, and T.K. Archer Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking Mol Cell Biol 22 2002 4113 4123
37. P. Dewint, V. Gossye, K. De Bosscher, W. Vanden Berghe, K. Van Beneden, and D. Deforce A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis J Immunol 180 2008 2608 2615
38. Z. Drebert, M. Bracke, and I.M. Beck Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts J Steroid Biochem Mol Biol 149 2015 92 105
39. K. Edman, R. Ahlgren, M. Bengtsson, H. Bladh, S. Backstrom, and J. Dahmen The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation Bioorg Med Chem Lett 24 2014 2571 2577
40. R. Frijters, W. Fleuren, E.J. Toonen, J.P. Tuckermann, H.M. Reichardt, and H. van der Maaden Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor BMC Genomics 11 2010 359
41. A.J. Galliher-Beckley, J.G. Williams, and J.A. Cidlowski Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling Mol Cell Biol 31 2011 4663 4675
42. V. Gossye, D. Elewaut, N. Bougarne, D. Bracke, S. Van Calenbergh, and G. Haegeman Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts Arthritis Rheum 60 2009 3241 3250
43. V. Gossye, D. Elewaut, K. Van Beneden, P. Dewint, G. Haegeman, and K. De Bosscher A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance Ann Rheum Dis 69 2010 291 296
44. H. Gronemeyer, J.A. Gustafsson, and V. Laudet Principles for modulation of the nuclear receptor superfamily Nat Rev Drug Discov 3 2004 950 964
45. R.J. Hache, R. Tse, T. Reich, J.G. Savory, and Y.A. Lefebvre Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor J Biol Chem 274 1999 1432 1439
46. A. Hakim, P.J. Barnes, I.M. Adcock, and O.S. Usmani Importin-7 mediates glucocorticoid receptor nuclear import and is impaired by oxidative stress, leading to glucocorticoid insensitivity FASEB J 27 2013 4510 4519
47. P.O. Hasselgren, N. Alamdari, Z. Aversa, P. Gonnella, I.J. Smith, and S. Tizio Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation Curr Opin Clin Nutr Metab Care 13 2010 423 428
48. S. Heck, M. Kullmann, A. Gast, H. Ponta, H.J. Rahmsdorf, and P. Herrlich A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1 EMBO J 13 1994 4087 4095
49. X. Hu, S. Du, C. Tunca, T. Braden, K.R. Long, and J. Lee The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation Endocrinology 152 2011 3123 3134
50. E.L. Humphrey, J.H. Williams, M.W. Davie, and M.J. Marshall Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells Bone 38 2006 652 661
51. T. Huynh, K. Uaesoontrachoon, J.L. Quinn, K.S. Tatem, C.R. Heier, and J.H. Van Der Meulen Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice J Pathol 231 2013 223 235
52. K. Ito, K.F. Chung, and I.M. Adcock Update on glucocorticoid action and resistance J Allergy Clin Immunol 117 2006 522 543
53. K. Ito, S.J. Getting, and C.E. Charron Mode of glucocorticoid actions in airway disease ScientificWorldJournal 6 2006 1750 1769
54. C.M. Jewell, A.B. Scoltock, B.L. Hamel, M.R. Yudt, and J.A. Cidlowski Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells Mol Endocrinol 26 2012 244 256
55. E. Joanny, Q. Ding, L. Gong, P. Kong, J. Saklatvala, and A.R. Clark Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1 Br J Pharmacol 165 2012 1124 1136
56. T. Kino, E. Charmandari, and G.P. Chrousos Glucocorticoid receptor: implications for rheumatic diseases Clin Exp Rheumatol 29 2011 S32 S41
57. P. Kowalczyk, M.C. Kowalczyk, J.J. Junco, O. Tolstykh, T. Kinjo, and H. Truong The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A Mol Carcinog 52 2013 488 496
58. L.J. Lewis-Tuffin, and J.A. Cidlowski The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance Ann N Y Acad Sci 1069 2006 1 9
59. F.J. López, R.J. Ardecky, B. Bebo, K. Benbatoul, L. De Grandpre, and S. Liu LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo Endocrinology 149 2008 2080 2089
60. A. Louw, and P. Swart Salsola tuberculatiformis Botschantzev and an aziridine precursor analog mediate the in vivo increase in free corticosterone and decrease in corticosteroid-binding globulin in female Wistar rats Endocrinology 140 1999 2044 2053
61. N.Z. Lu, and J.A. Cidlowski The origin and functions of multiple human glucocorticoid receptor isoforms Ann N Y Acad Sci 1024 2004 102 123
62. K. Ma, C. Mallidis, S. Bhasin, V. Mahabadi, J. Artaza, and N. Gonzalez-Cadavid Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression Am J Physiol Endocrinol Metab 285 2003 E363 E371
63. O. Malaise, B. Relic, E. Charlier, S. Neuville, D. de Seny, and M. Malaise The glucocorticoid-induced leucine zipper (GILZ) protein is involved in corticosteroid-induced leptin production by human osteoarthritis synovial fibroblasts in vitro Osteoarthritis Cartilage 22 2015
64. O. Malaise, B. Relic, F. Quesada-Calvo, E. Charlier, M. Zeddou, and S. Neuville Selective glucocorticoid receptor modulator compound A, in contrast to prednisolone, does not induce leptin or the leptin receptor in human osteoarthritis synovial fibroblasts Rheumatology (Oxford) 2014 10.1093/rheumatology/keu428
65. V. Malhotra, and H.R. Wong Interactions between the heat shock response and the nuclear factor-kappa B signaling pathway Crit Care Med 30 2002 S89 S95
66. A.K. McDonough, J.R. Curtis, and K.G. Saag The epidemiology of glucocorticoid-associated adverse events Curr Opin Rheumatol 20 2008 131 137
67. A. McMaster, and D.W. Ray Drug insight: selective agonists and antagonists of the glucocorticoid receptor Nat Clin Pract Endocrinol Metab 4 2008 91 101
68. S.H. Meijsing, M.A. Pufall, A.Y. So, D.L. Bates, L. Chen, and K.R. Yamamoto DNA binding site sequence directs glucocorticoid receptor structure and activity Science 324 2009 407 410
69. N. Mercado, A. Hakim, Y. Kobayashi, S. Meah, O.S. Usmani, and K.F. Chung Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma PLoS One 7 2012 (e41582)
70. T. Meyer, J.A. Gustafsson, and J. Carlstedt-Duke Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box DNA Cell Biol 16 1997 919 927
71. J.N. Miner, B. Ardecky, K. Benbatoul, K. Griffiths, C.J. Larson, and D.E. Mais Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile Proc Natl Acad Sci U S A 104 2007 19244 19249
72. N. Nader, G.P. Chrousos, and T. Kino Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications FASEB J 23 2009 1572 1583
73. R. Newton Anti-inflammatory glucocorticoids: changing concepts Eur J Pharmacol 724 2014 231 236
74. R. Newton, and N.S. Holden Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol 72 2007 799 809
75. N.C. Nicolaides, E. Charmandari, G.P. Chrousos, and T. Kino Circadian endocrine rhythms: the hypothalamic-pituitary-adrenal axis and its actions Ann N Y Acad Sci 1318 2014 71 80
76. M. Nixon, R. Andrew, and K.E. Chapman It takes two to tango: dimerisation of glucocorticoid receptor and its anti-inflammatory functions Steroids 78 2013 59 68
77. A.W. Norman, M.T. Mizwicki, and D.P. Norman Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model Nat Rev Drug Discov 3 2004 27 41
78. R.H. Oakley, and J.A. Cidlowski Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids J Biol Chem 286 2011 3177 3184
79. R.H. Oakley, and J.A. Cidlowski The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease J Allergy Clin Immunol 132 2013 1033 1044
80. H.C. Owen, J.N. Miner, S.F. Ahmed, and C. Farquharson The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438 Mol Cell Endocrinol 264 2007 164 170
81. A. Papi, M. Contoli, I.M. Adcock, C. Bellettato, A. Padovani, and P. Casolari Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun N-terminal kinase activation J Allergy Clin Immunol 132 2013 1075 1085 (e1076)
82. D.M. Presman, M.F. Ogara, M. Stortz, L.D. Alvarez, J.R. Pooley, and R.L. Schiltz Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor PLoS Biol 12 2014 (e1001813)
83. R.A. Quax, L. Manenschijn, J.W. Koper, J.M. Hazes, S.W. Lamberts, and E.F. van Rossum Glucocorticoid sensitivity in health and disease Nat Rev Endocrinol 9 2013 670 686
84. S. Ramamoorthy, and J.A. Cidlowski Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements Mol Cell Biol 33 2013 1711 1722
85. A. Rauch, V. Gossye, D. Bracke, E. Gevaert, P. Jacques, and K. Van Beneden An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation FASEB J 25 2011 1323 1332
86. A. Rauch, S. Seitz, U. Baschant, A.F. Schilling, A. Illing, and B. Stride Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor Cell Metab 11 2010 517 531
87. M. Rauner, S. Thiele, K. Sinningen, M. Winzer, J. Salbach-Hirsch, and I. Gloe Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis Endocrinology 154 2013 3719 3728
88. H. Razavi, D. Riether, C. Harcken, J. Bentzien, R.M. Dinallo, and D. Souza Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore Bioorg Med Chem Lett 24 2014 1934 1940
89. L.L. Reber, F. Daubeuf, M. Plantinga, L. De Cauwer, S. Gerlo, and W. Waelput A dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a mouse model of asthma J Immunol 188 2012 3478 3487
90. E.K. Reeves, S. Rayavarapu, J.M. Damsker, and K. Nagaraju Glucocorticoid analogues: potential therapeutic alternatives for treating inflammatory muscle diseases Endocr Metab Immune Disord Drug Targets 12 2012 95 103
91. H.M. Reichardt, K.H. Kaestner, J. Tuckermann, O. Kretz, O. Wessely, and R. Bock DNA binding of the glucocorticoid receptor is not essential for survival Cell 93 1998 531 541
92. S.D. Reichardt, T. Weinhage, A. Rotte, M. Foller, M. Oppermann, and F. Luhder Glucocorticoids induce gastroparesis in mice through depletion of l-arginine Endocrinology 155 2014 3899 3908
93. B. Relic, M. Zeddou, A. Desoroux, Y. Beguin, D. de Seny, and M.G. Malaise Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts Lab Invest 89 2009 811 822
94. K.C. Reuter, C.R. Grunwitz, B.M. Kaminski, D. Steinhilber, H.H. Radeke, and J. Stein Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis J Pharmacol Exp Ther 341 2012 68 80
95. K.C. Reuter, S.M. Loitsch, A.U. Dignass, D. Steinhilber, and J. Stein Selective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitro PLoS One 7 2012 (e29756)
96. T. Rhen, and J.A. Cidlowski Antiinflammatory action of glucocorticoids-new mechanisms for old drugs N Engl J Med 353 2005 1711 1723
97. S. Robertson, F. Allie-Reid, W. Vanden Berghe, K. Visser, A. Binder, and D. Africander Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a J Biol Chem 285 2010 8061 8075
98. S. Robertson, J.P. Hapgood, and A. Louw Glucocorticoid receptor concentration and the ability to dimerize influence nuclear translocation and distribution Steroids 78 2013 182 194
99. S. Robertson, J.M. Rohwer, J.P. Hapgood, and A. Louw Impact of glucocorticoid receptor density on ligand-independent dimerization, cooperative ligand-binding and basal priming of transactivation: a cell culture model PLoS One 8 2013 (e64831)
100. K. Ronacher, K. Hadley, C. Avenant, E. Stubsrud, S.S. Simons Jr., and A. Louw Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction Mol Cell Endocrinol 299 2009 219 231
101. J. Rosen, and J.N. Miner The search for safer glucocorticoid receptor ligands Endocr Rev 26 2005 452 464
102. C. Rossios, Y. To, G. Osoata, M. Ito, P.J. Barnes, and K. Ito Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition Br J Pharmacol 167 2012 775 786
103. T. Saksida, M. Vujicic, I. Nikolic, I. Stojanovic, G. Haegeman, and S. Stosic-Grujicic Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice Br J Pharmacol 171 2014 5898 5909
104. H. Schacke, M. Berger, H. Rehwinkel, and K. Asadullah Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index Mol Cell Endocrinol 275 2007 109 117
105. H. Schacke, W.D. Docke, and K. Asadullah Mechanisms involved in the side effects of glucocorticoids Pharmacol Ther 96 2002 23 43
106. H. Schacke, A. Schottelius, W.D. Docke, P. Strehlke, S. Jaroch, and N. Schmees Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects Proc Natl Acad Sci U S A 101 2004 227 232
107. H. Schacke, T.M. Zollner, W.D. Docke, H. Rehwinkel, S. Jaroch, and W. Skuballa Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases Br J Pharmacol 158 2009 1088 1103
108. S. Shah, E.M. King, A. Chandrasekhar, and R. Newton Roles for the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, in feedback control of inflammatory gene expression and repression by dexamethasone J Biol Chem 289 2014 13667 13679
109. S.S. Simons Jr., D.P. Edwards, and R. Kumar Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges Mol Endocrinol 28 2014 173 182
110. L.K. Smith, and J.A. Cidlowski Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes Prog Brain Res 182 2010 1 30
111. S.L. Spinelli, X. Xi, D.H. McMillan, C.F. Woeller, M.E. Richardson, and M.E. Cavet Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells Exp Eye Res 127 2014 290 298
112. C. Stahn, and F. Buttgereit Genomic and nongenomic effects of glucocorticoids Nat Clin Pract Rheumatol 4 2008 525 533
113. T. Stock, D. Fleishaker, A. Mukherjee, V. Le, J. Xu, and B. Zeiher Evaluation of safety, pharmacokinetics and pharmacodynamics of a selective glucocorticoid receptor modulator (SGRM) in healthy volunteers Arthritis Rheum 60 2009 420
114. M. Surjit, K.P. Ganti, A. Mukherji, T. Ye, G. Hua, and D. Metzger Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor Cell 145 2011 224 241
115. C.R. Tchen, J.R. Martins, N. Paktiawal, R. Perelli, J. Saklatvala, and A.R. Clark Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence J Biol Chem 285 2010 2642 2652
116. S. Thiele, N. Ziegler, E. Tsourdi, K. De Bosscher, J.P. Tuckermann, and L.C. Hofbauer Selective glucocorticoid receptor modulation maintains bone mineral density in mice J Bone Miner Res 27 2012 2242 2250
117. J.P. Tuckermann, A. Kleiman, R. Moriggl, R. Spanbroek, A. Neumann, and A. Illing Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy J Clin Invest 117 2007 1381 1390
118. USNIH NCT00812825: A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers 2014 Pfizer
119. USNIH NCT00905450: Evaluation of BOL-303242-X versus vehicle for the treatment of inflammation following cataract surgery 2014 Bausch & Lomb Incorporated
120. USNIH NCT00938587: a study of PF-04171327 in the treatment of the signs and symptoms of rheumatoid arthritis 2014 Pfizer
121. USNIH NCT00944632: dose escalation of different concentrations of ZK 245186 in atopic dermatitis 2014 Bayer
122. USNIH NCT00987038: a midazolam Drug interaction study with PF-04171327 2014 Pfizer
123. USNIH NCT01199900: single dose study of PF-04171327 and prednisone on carbohydrate metabolism 2014 Pfizer
124. USNIH NCT01228513: efficacy and safety of different concentrations of ZK245186 in atopic dermatitis (AD) 2014 Bayer
125. USNIH NCT01230125: mapracorat ophthalmic suspension for the treatment of ocular inflammation following cataract surgery 2014 Bausch & Lomb Incorporated
126. USNIH NCT01289431: mapracorat ophthalmic formulation in subjects with allergic conjunctivitis 2014 Bausch & Lomb Incorporated
127. USNIH NCT01359787: efficacy and safety of different concentrations of mapracorat ointment over 4 weeks in atopic dermatitis (AD) 2014 Bayer
128. USNIH NCT01362673: PK and safety study of PF-04171327 in healthy japanese and western subjects in fasting and Fed conditions 2014 Pfizer
129. USNIH NCT01393639: study comparing doses of an experimental glucocorticoid compound to prednisone and placebo in rheumatoid arthritis 2014 Pfizer
130. USNIH NCT01407510: HPA axis study in Japanese adults 2014 Bayer
131. USNIH NCT01408511: HPA axis study in adults 2014 Bayer
132. USNIH NCT01591161: mapracorat ophthalmic suspension, 3% for the treatment of ocular inflammation and pain following cataract surgery 2014 Bausch & Lomb Incorporated
133. USNIH NCT01591655: mapracorat ophthalmic suspension, 3% for the treatment of ocular inflammation and pain following cataract surgery 2014 Bausch & Lomb Incorporated
134. USNIH NCT01736462: corneal endothelial cell density changes, when mapracorat ophthalmic suspension 3%, is administered for 14 days 2014 Bausch & Lomb Incorporated
135. T. Van Bogaert, K. De Bosscher, and C. Libert Crosstalk between TNF and glucocorticoid receptor signaling pathways Cytokine Growth Factor Rev 21 2010 275 286
136. M.J. van Lierop, W. Alkema, A.J. Laskewitz, R. Dijkema, H.M. van der Maaden, and M.J. Smit Org 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic index PLoS One 7 2012 (e48385)
137. G. van Loo, M. Sze, N. Bougarne, J. Praet, C. Mc Guire, and A. Ullrich Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis Mol Endocrinol 24 2010 310 322
138. E.F. van Rossum, and S.W. Lamberts Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach Best Pract Res Clin Endocrinol Metab 20 2006 611 626
139. S. Vandevyver, L. Dejager, and C. Libert On the trail of the glucocorticoid receptor: into the nucleus and back Traffic 13 2012 364 374
140. S. Vandevyver, L. Dejager, and C. Libert Comprehensive overview of the structure and regulation of the glucocorticoid receptor Endocr Rev 35 2014 671 693
141. S. Vandevyver, L. Dejager, T. Van Bogaert, A. Kleyman, Y. Liu, and J. Tuckermann Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation J Clin Invest 122 2012 2130 2140
142. Q. Wang, J.A. Blackford Jr., L.N. Song, Y. Huang, S. Cho, and S.S. Simons Jr. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors Mol Endocrinol 18 2004 1376 1395
143. L.C. Watson, K.M. Kuchenbecker, B.J. Schiller, J.D. Gross, M.A. Pufall, and K.R. Yamamoto The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals Nat Struct Mol Biol 20 2013 876 883
144. J.C. Webster, C.M. Jewell, J.E. Bodwell, A. Munck, M. Sar, and J.A. Cidlowski Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein J Biol Chem 272 1997 9287 9293
145. Y.G. Weiss, Z. Bromberg, N. Raj, J. Raphael, P. Goloubinoff, and Y. Ben-Neriah Enhanced heat shock protein 70 expression alters proteasomal degradation of IkappaB kinase in experimental acute respiratory distress syndrome Crit Care Med 35 2007 2128 2138
146. I. Wu, S.C. Shin, Y. Cao, I.K. Bender, N. Jafari, and G. Feng Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes Cell Death Dis 4 2013 (e453)
147. S. Wust, D. Tischner, M. John, J.P. Tuckermann, C. Menzfeld, and U.K. Hanisch Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis PLoS One 4 2009 (e8202)
148. N. Yang, G. Caratti, L.M. Ince, T.M. Poolman, P.J. Trebble, and C.M. Holt Serum cholesterol selectively regulates glucocorticoid sensitivity through activation of JNK J Endocrinol 223 2014 155 166
149. N. Yang, D.W. Ray, and L.C. Matthews Current concepts in glucocorticoid resistance Steroids 77 2012 1041 1049
150. A. Yemelyanov, J. Czwornog, L. Gera, S. Joshi, R.T. Chatterton Jr., and I. Budunova Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells Cancer Res 68 2008 4763 4773
151. I. Zalachoras, R. Houtman, E. Atucha, R. Devos, A.M. Tijssen, and P. Hu Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator Proc Natl Acad Sci U S A 110 2013 7910 7915
152. J.Z. Zhang, M.E. Cavet, K.R. VanderMeid, M. Salvador-Silva, F.J. Lopez, and K.W. Ward BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells Mol Vis 15 2009 2606 2616
153. Z. Zhang, Z.Y. Zhang, and H.J. Schluesener Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects J Immunol 183 2009 3081 3091
154. B. Zheng, S. Ohkawa, H. Li, T.K. Roberts-Wilson, and S.R. Price FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy FASEB J 24 2010 2660 2669